Cargando…

Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach

OBJECTIVES: To evaluate the performance of radiomics features extracted from planning target volume (PTV) and gross tumor volume (GTV) in the prediction of the death prognosis and cancer recurrence rate for head and neck squamous cell carcinoma (HNSCC). METHODS: 188 HNSCC patients’ planning CT image...

Descripción completa

Detalles Bibliográficos
Autores principales:	FH, Tang, CYW, Chu, EYW, Cheung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Institute of Radiology. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320130/ https://www.ncbi.nlm.nih.gov/pubmed/34381946 http://dx.doi.org/10.1259/bjro.20200073

Ejemplares similares

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
por: Lemaire, F, et al.
Publicado: (2003)

Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
por: Baa, Annie Kanchan, et al.
Publicado: (2023)

Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC)
por: Pérez Sayáns, Mario, et al.
Publicado: (2019)

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
por: Shiiba, Masashi, et al.
Publicado: (2010)

Radiomics from Various Tumour Volume Sizes for Prognosis Prediction of Head and Neck Squamous Cell Carcinoma: A Voted Ensemble Machine Learning Approach
por: Tang, Fuk-Hay, et al.
Publicado: (2022)

Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)
por: Echarri, María José, et al.
Publicado: (2016)

Comprehensive Geriatric Assessment and Quality of Life Aspects in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Winter, Anna, et al.
Publicado: (2023)

The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
por: Hakami, F, et al.
Publicado: (2014)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Predictive models for stage and risk classification in head and neck squamous cell carcinoma (HNSCC)
por: Kumar, Sugandh, et al.
Publicado: (2020)

MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
por: Huang, Tian-qiao, et al.
Publicado: (2020)

FN1 promotes prognosis and radioresistance in head and neck squamous cell carcinoma: From radioresistant HNSCC cell line to integrated bioinformatics methods
por: Tang, Xiaojun, et al.
Publicado: (2022)

Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Pectasides, Eirini, et al.
Publicado: (2014)

Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients
por: Friemel, Juliane, et al.
Publicado: (2016)

Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Weller, Patrick, et al.
Publicado: (2014)

Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC)
por: Chan, Chien-Yi, et al.
Publicado: (2016)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
por: Gao, Lei, et al.
Publicado: (2022)

Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
por: Liu, Shutong, et al.
Publicado: (2017)

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
por: Panchal, Omkar, et al.
Publicado: (2020)

Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC)
por: Katase, Naoki, et al.
Publicado: (2022)

Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Hashmi, Atif A, et al.
Publicado: (2023)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Huehn, Marius, et al.
Publicado: (2021)

Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma
por: Fatima, Kashuf, et al.
Publicado: (2021)

Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC)
por: Abdelaziz, Tougan Taha, et al.
Publicado: (2020)

Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC)
por: Sticht, C, et al.
Publicado: (2005)

Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Bauer, Verena L., et al.
Publicado: (2010)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014)

The α2-HeremansSchmid glycoprotein (AHSG) promotes growth in head and neck squamous cell carcinoma (HNSCC)
por: Thompson, Pamela D, et al.
Publicado: (2013)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Ebnoether, Eliane, et al.
Publicado: (2020)

Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Irimie-Aghiorghiesei, Alexandra Iulia, et al.
Publicado: (2019)

Tumour volume measurement in head and neck cancer
por: Chong, Vincent F.H.
Publicado: (2007)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume
por: Nissi, Linda, et al.
Publicado: (2021)

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)()
por: Almeida, Luciana O., et al.
Publicado: (2013)

MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)
por: Zhang, Jiali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l973ds4mh3g5mvo83usa3hq5sr